养心氏片联合左甲状腺素钠治疗甲状腺功能减退性心脏病疗效分析
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

广西卫生厅自筹经费科研课题——左甲状腺素钠替代治疗甲状腺功能减退症对血管内皮功能影响的临床研究(编号:z2014019)


Therapeutic Effect Analysisi of Yangxin Tablet Combined with Levothyroxine Sodium in Treatment of Hypothyroid Heart Disease
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察养心氏片联合左甲状腺素钠治疗甲状腺功能减退性心脏病疗效分析。方法:治疗组150例养心氏片联合左甲状腺素钠治疗;对照组100例单纯左甲状腺素钠治疗。结果:治疗组总有效率97.37%,明显优于对照组75.76%(P<0.05)。2组治疗后T3、T4、FT3、FT4、TSH、LVEF、ATIII、FIB、TM较本组治疗前均有改善(P<0.05);且治疗组治疗后T3、T4、FT3、FT4、TSH、LVEF、ATIII、FIB、TM均优于对照组治疗后(P<0.05)。结论:养心氏片联合优甲乐治疗甲状腺功能减退性心脏病疗效显著、改善症状快速,且无明显不良反应。

    Abstract:

    To observe curative effect analysis Yangxin Tablet combined with levothyroxine sodium in treatment of hypothyroid heart disease. Methods:The treatment group included 150 cases, given the treatment of yangxin tablet combined with levothyroxine sodium, while patients in the control group with 100 cases were only given levothyroxine sodium treatment. Results:The total effectiveness of the treatment group was 97.37% and was obviously better than that of the control group (75.76%) with statistical significant difference (P<0.05). T3, T4, FT3, FT4, TSH, LVEF, ATIII, FIB, and TM of both the two groups after treatment were improved, compared with those before treatment (P<0.05) and those of the treatment group were superior to those of the control group (P<0.05). Conclusion:The curative effect of Yangxin Tablet combined with levothyroxine sodium in treatment of hypothyroid heart disease is distinct, with fast symptoms improvement and no obvious side effects.

    参考文献
    相似文献
    引证文献
引用本文

潘伟,陈聿峰,韦彩芬.养心氏片联合左甲状腺素钠治疗甲状腺功能减退性心脏病疗效分析[J].世界中医药,2016,(05).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2016-03-29
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2016-05-18
  • 出版日期:
文章二维码